Ms. Vicki L. Goodman's most recent trade in Exelixis Inc was a trade of 82,566 Common Stock done . Disclosure was reported to the exchange on April 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | Ms. Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 82,566 | 307,654 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Ms. Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.08 per share. | 15 Feb 2023 | 17,299 | 225,088 (0%) | 0% | 18.1 | 312,766 | Common Stock |
| Exelixis Inc | Ms. Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Ms. Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 04 Jan 2022 | 7,613 | 242,387 (0%) | 0% | 19.2 | 146,017 | Common Stock |